Are we closer to being able to select patients with node-positive hormone receptor-positive breast cancer who can safely omit chemotherapy?

por Taylor, Caitlin, Meisel, Jane, Kalinsky, Kevin
Publicado 2022

Trop-2 as a Therapeutic Target in Breast Cancer

por Sakach, Elizabeth, Sacks, Ruth, Kalinsky, Kevin
Publicado 2022

Concomitant angiosarcoma and lymphoproliferative disorder in solid organ transplant recipients

por Baer, Lea N, Savage, David G, Hibshoosh, Hanina H, Kalinsky, Kevin
Publicado 2014

Monitoring Metastasis and Cachexia in a Patient with Breast Cancer: A Case Study

por Consul, Nikita, Guo, Xiaotao, Coker, Courtney, Lopez-Pintado, Sara, Hibshoosh, Hanina, Zhao, Binsheng, Kalinsky, Kevin, Acharyya, Swarnali
Publicado 2016

Characteristics and outcomes of patients with breast cancer diagnosed with SARS-Cov-2 infection at an academic center in New York City

por Kalinsky, Kevin, Accordino, Melissa K., Hosi, Kristina, Hawley, Jessica E., Trivedi, Meghna S., Crew, Katherine D., Hershman, Dawn L.
Publicado 2020

Therapeutic Targeting of Minimal Residual Disease to Prevent Late Recurrence in Hormone-Receptor Positive Breast Cancer: Challenges and New Approaches

por Cescon, David W., Kalinsky, Kevin, Parsons, Heather A., Smith, Karen Lisa, Spears, Patricia A., Thomas, Alexandra, Zhao, Fengmin, DeMichele, Angela
Publicado 2022

Identifying Predictors of Taxane-Induced Peripheral Neuropathy Using Mass Spectrometry-Based Proteomics Technology

por Chen, Emily I., Crew, Katherine D., Trivedi, Meghna, Awad, Danielle, Maurer, Mathew, Kalinsky, Kevin, Koller, Antonius, Patel, Purvi, Kim Kim, Jenny, Hershman, Dawn L.
Publicado 2015

Molecular differences between younger versus older ER-positive and HER2-negative breast cancers

por Qing, Tao, Karn, Thomas, Rozenblit, Mariya, Foldi, Julia, Marczyk, Michal, Shan, Naing Lin, Blenman, Kim, Holtrich, Uwe, Kalinsky, Kevin, Meric-Bernstam, Funda, Pusztai, Lajos
Publicado 2022

Higher locoregional recurrence rate for triple-negative breast cancer following neoadjuvant chemotherapy, surgery and radiotherapy

por Zhang, Chi, Wang, Shuang, Israel, Hayley P, Yan, Sherry X, Horowitz, David P, Crockford, Seth, Gidea-Addeo, Daniela, Clifford Chao, K S, Kalinsky, Kevin, Connolly, Eileen P
Publicado 2015

Effects of neoadjuvant chemotherapy on the contralateral non-tumor-bearing breast assessed by diffuse optical tomography

por Altoe, Mirella L., Kalinsky, Kevin, Marone, Alessandro, Kim, Hyun K., Guo, Hua, Hibshoosh, Hanina, Tejada, Mariella, Crew, Katherine D., Accordino, Melissa K., Trivedi, Meghna S., Hershman, Dawn L., Hielscher, Andreas H.
Publicado 2021

Proteolytic regulation of CD73 by TRIM21 orchestrates tumor immunogenicity

por Fu, Ziyi, Chen, Siqi, Zhu, Yueming, Zhang, Donghong, Xie, Ping, Jiao, Qiao, Chi, Junlong, Xu, Shipeng, Xue, Yifan, Lu, Xinghua, Song, Xinxin, Cristofanilli, Massimo, Gradishar, William J., Kalinsky, Kevin, Yin, Yongmei, Zhang, Bin, Wan, Yong
Publicado 2023

An analysis of the relationship between metastases and cachexia in lung cancer patients

por Shiono, Masatoshi, Huang, Kan, Downey, Robert J., Consul, Nikita, Villanueva, Nicolas, Beck, Kristen, Fenn, Kathleen, Dietz, Donald, Yamaguchi, Takuhiro, Kato, Shunsuke, Divgi, Chaitanya, Kalinsky, Kevin, Wei, Ying, Zhang, Yuan, Borczuk, Alain C., Inoue, Akira, Halmos, Balazs, Acharyya, Swarnali
Publicado 2016

Akt Inhibition Is Associated With Favorable Immune Profile Changes Within the Tumor Microenvironment of Hormone Receptor Positive, HER2 Negative Breast Cancer

por Marks, Douglas K., Gartrell, Robyn D., El Asmar, Margueritta, Boboila, Shuobo, Hart, Thomas, Lu, Yan, Pan, Qingfei, Yu, Jiyang, Hibshoosh, Hanina, Guo, Hua, Andreopoulou, Eleni, Wiechmann, Lisa, Crew, Katherine, Sparano, Joseph, Hershman, Dawn, Connolly, Eileen, Saenger, Yvonne, Kalinsky, Kevin
Publicado 2020

Phase I/II Trial of Ruxolitinib in Combination with Trastuzumab in Metastatic HER2 Positive Breast Cancer

por Kearney, Matthew, Franks, Lauren, Lee, Shing, Tiersten, Amy, Makower, Della F, Cigler, Tessa, Mundi, Prabhjot, Chi, Dow-Chung, Goel, Anupama, Klein, Pam, Andreopoulou, Eleni, Sparano, Joseph, Trivedi, Meghna, Accordino, Melissa, Califano, Andrea, Hershman, Dawn L, Silva, Jose, Kalinsky, Kevin
Publicado 2021

Analysis of patients without and with an initial triple-negative breast cancer diagnosis in the phase 3 randomized ASCENT study of sacituzumab govitecan in metastatic triple-negati...

por O’Shaughnessy, Joyce, Brufsky, Adam, Rugo, Hope S., Tolaney, Sara M., Punie, Kevin, Sardesai, Sagar, Hamilton, Erika, Loirat, Delphine, Traina, Tiffany, Leon-Ferre, Roberto, Hurvitz, Sara A., Kalinsky, Kevin, Bardia, Aditya, Henry, Stephanie, Mayer, Ingrid, Zhu, Yanni, Phan, See, Cortés, Javier
Publicado 2022

Inhibition of the autocrine IL-6–JAK2–STAT3–calprotectin axis as targeted therapy for HR(−)/HER2(+) breast cancers

por Rodriguez-Barrueco, Ruth, Yu, Jiyang, Saucedo-Cuevas, Laura P., Olivan, Mireia, Llobet-Navas, David, Putcha, Preeti, Castro, Veronica, Murga-Penas, Eva M., Collazo-Lorduy, Ana, Castillo-Martin, Mireia, Alvarez, Mariano, Cordon-Cardo, Carlos, Kalinsky, Kevin, Maurer, Matthew, Califano, Andrea, Silva, Jose M.
Publicado 2015

Safety analyses from the phase 3 ASCENT trial of sacituzumab govitecan in metastatic triple-negative breast cancer

por Rugo, Hope S., Tolaney, Sara M., Loirat, Delphine, Punie, Kevin, Bardia, Aditya, Hurvitz, Sara A., O’Shaughnessy, Joyce, Cortés, Javier, Diéras, Véronique, Carey, Lisa A., Gianni, Luca, Piccart, Martine J., Loibl, Sibylle, Goldenberg, David M., Hong, Quan, Olivo, Martin, Itri, Loretta M., Kalinsky, Kevin
Publicado 2022

Sacituzumab govitecan as second-line treatment for metastatic triple-negative breast cancer—phase 3 ASCENT study subanalysis

por Carey, Lisa A., Loirat, Delphine, Punie, Kevin, Bardia, Aditya, Diéras, Véronique, Dalenc, Florence, Diamond, Jennifer R., Fontaine, Christel, Wang, Grace, Rugo, Hope S., Hurvitz, Sara A., Kalinsky, Kevin, O’Shaughnessy, Joyce, Loibl, Sibylle, Gianni, Luca, Piccart, Martine, Zhu, Yanni, Delaney, Rosemary, Phan, See, Cortés, Javier
Publicado 2022

If we build it they will come: targeting the immune response to breast cancer

por Gatti-Mays, Margaret E., Balko, Justin M., Gameiro, Sofia R., Bear, Harry D., Prabhakaran, Sangeetha, Fukui, Jami, Disis, Mary L., Nanda, Rita, Gulley, James L., Kalinsky, Kevin, Abdul Sater, Houssein, Sparano, Joseph A., Cescon, David, Page, David B., McArthur, Heather, Adams, Sylvia, Mittendorf, Elizabeth A.
Publicado 2019

Serial single-cell genomics reveals convergent subclonal evolution of resistance as early-stage breast cancer patients progress on endocrine plus CDK4/6 therapy

por Griffiths, Jason I., Chen, Jinfeng, Cosgrove, Patrick A., O’Dea, Anne, Sharma, Priyanka, Ma, Cynthia, Trivedi, Meghna, Kalinsky, Kevin, Wisinski, Kari B., O’Regan, Ruth, Makhoul, Issam, Spring, Laura M., Bardia, Aditya, Adler, Frederick R., Cohen, Adam L., Chang, Jeffrey T., Khan, Qamar J., Bild, Andrea H.
Publicado 2021